Disease activity and biologic use in patients with psoriatic arthritis or rheumatoid arthritis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1434-9949
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Disease activity and biologic use in patients with psoriatic arthritis or rheumatoid arthritis ; volume:37 ; number:8 ; day:4 ; month:6 ; year:2018 ; pages:2275-2280 ; date:8.2018
Clinical rheumatology ; 37, Heft 8 (4.6.2018), 2275-2280, 8.2018
- Creator
-
Kavanaugh, Arthur
- Contributor
-
Singh, Rakesh
Karki, Chitra
Etzel, Carol J.
Kremer, Joel M.
Greenberg, Jeffrey D.
Griffith, Jenny
SpringerLink (Online service)
- DOI
-
10.1007/s10067-018-4140-0
- URN
-
urn:nbn:de:101:1-2018091820104343817970
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:30 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kavanaugh, Arthur
- Singh, Rakesh
- Karki, Chitra
- Etzel, Carol J.
- Kremer, Joel M.
- Greenberg, Jeffrey D.
- Griffith, Jenny
- SpringerLink (Online service)
Other Objects (12)
Prevalence of methotrexate intolerance in rheumatoid arthritis and psoriatic arthritis
Drug interactions in the treatment of rheumatoid arthritis and psoriatic arthritis
Administration costs of intravenous biologic drugs for rheumatoid arthritis
Itolizumab – A New Biologic for Management of Psoriasis and Psoriatic Arthritis
Economic impact of biologic utilization patterns in patients with psoriatic arthritis
Patient-centered psoriatic arthritis (PsA) activity assessment by Stockerau Activity Score for Psoriatic Arthritis (SASPA)
Metabolic profiling in rheumatoid arthritis, psoriatic arthritis, and psoriasis: elucidating pathogenesis, improving diagnosis, and monitoring disease activity
Differential synovial tissue biomarkers among psoriatic arthritis and rheumatoid factor/anti-citrulline antibody-negative rheumatoid arthritis
A comparative study of periarticular bone lesions in rheumatoid arthritis and psoriatic arthritis
Do biologic therapies reduce aortic inflammation in rheumatoid arthritis patients?
Treatment Switch Patterns and Healthcare Costs in Biologic-Naive Patients with Psoriatic Arthritis
Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics
Prevalence of methotrexate intolerance in rheumatoid arthritis and psoriatic arthritis
Drug interactions in the treatment of rheumatoid arthritis and psoriatic arthritis
Administration costs of intravenous biologic drugs for rheumatoid arthritis
Itolizumab – A New Biologic for Management of Psoriasis and Psoriatic Arthritis
Economic impact of biologic utilization patterns in patients with psoriatic arthritis
Patient-centered psoriatic arthritis (PsA) activity assessment by Stockerau Activity Score for Psoriatic Arthritis (SASPA)
Metabolic profiling in rheumatoid arthritis, psoriatic arthritis, and psoriasis: elucidating pathogenesis, improving diagnosis, and monitoring disease activity
Differential synovial tissue biomarkers among psoriatic arthritis and rheumatoid factor/anti-citrulline antibody-negative rheumatoid arthritis
A comparative study of periarticular bone lesions in rheumatoid arthritis and psoriatic arthritis
Do biologic therapies reduce aortic inflammation in rheumatoid arthritis patients?
Treatment Switch Patterns and Healthcare Costs in Biologic-Naive Patients with Psoriatic Arthritis
Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics
Prevalence of methotrexate intolerance in rheumatoid arthritis and psoriatic arthritis
Drug interactions in the treatment of rheumatoid arthritis and psoriatic arthritis
Administration costs of intravenous biologic drugs for rheumatoid arthritis
Itolizumab – A New Biologic for Management of Psoriasis and Psoriatic Arthritis
Economic impact of biologic utilization patterns in patients with psoriatic arthritis
Patient-centered psoriatic arthritis (PsA) activity assessment by Stockerau Activity Score for Psoriatic Arthritis (SASPA)
Metabolic profiling in rheumatoid arthritis, psoriatic arthritis, and psoriasis: elucidating pathogenesis, improving diagnosis, and monitoring disease activity
Differential synovial tissue biomarkers among psoriatic arthritis and rheumatoid factor/anti-citrulline antibody-negative rheumatoid arthritis
A comparative study of periarticular bone lesions in rheumatoid arthritis and psoriatic arthritis
Do biologic therapies reduce aortic inflammation in rheumatoid arthritis patients?
Treatment Switch Patterns and Healthcare Costs in Biologic-Naive Patients with Psoriatic Arthritis